GastroCE
LECTURECME

Advances in Ulcerative Colitis Management: Targeting Inflammation to Achieve Remission Across the Disease Spectrum

Author(s)/Faculty: David T. Rubin, MD; Stephen B. Hanauer, MD; Uma Mahadevan, MD; William J. Sandborn, MD
Release Date: 12/18/2015Expiration Date: 12/9/2017
Credit Type: CMENumber of Credits: 1.5
Content Type: LectureProvider: Vindico Medical Education

Although ulcerative colitis (UC) is globally one of the most common inflammatory bowel diseases, many patients continue to receive suboptimal therapy. Outcomes in UC are diminished by multiple factors, including physician uncertainty regarding approaches to treatment for newly diagnosed patients, confusion regarding the role of biologic and conventional therapies, and a lack of guidance on patient selection for early intensive treatment. As the therapeutic landscape for UC continues to evolve, physicians need to be aware of how these agents can be used to personalize therapy and optimize patient outcomes. In this activity, leading gastroenterologists will discuss the most current therapeutic advancements in the management of patients with UC.